Quadrant Private Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-99,530
| Closed | -$2.79M | – | 262 |
|
|
2026
Q1 | $2.79M | Sell |
99,530
-653
| -0.7% | -$17.4K | 0.43% | 71 |
|
|
2025
Q4 | $2.49M | Sell |
100,183
-7,898
| -7% | -$199K | 0.41% | 73 |
|
|
2025
Q3 | $2.75M | Buy |
108,081
+1,097
| +1% | +$27.1K | 0.5% | 56 |
|
|
2025
Q2 | $2.59M | Sell |
106,984
-12,001
| -10% | -$280K | 0.54% | 52 |
|
|
2025
Q1 | $3.02M | Buy |
118,985
+913
| +0.8% | +$23.9K | 0.75% | 39 |
|
|
2024
Q4 | $3.13M | Sell |
118,072
-17,099
| -13% | -$464K | 0.77% | 34 |
|
|
2024
Q3 | $3.91M | Buy |
135,171
+18,663
| +16% | +$544K | 0.97% | 27 |
|
|
2024
Q2 | $3.26M | Buy |
116,508
+20,651
| +22% | +$569K | 0.75% | 33 |
|
|
2024
Q1 | $2.66M | Buy |
95,857
+17,735
| +23% | +$492K | 0.67% | 40 |
|
|
2023
Q4 | $2.25M | Buy |
78,122
+8,175
| +12% | +$247K | 0.62% | 45 |
|
|
2023
Q3 | $2.32M | Buy |
69,947
+15,960
| +30% | +$564K | 0.78% | 32 |
|
|
2023
Q2 | $1.98M | Sell |
53,987
-52
| -0.1% | -$2.02K | 0.57% | 52 |
|
|
2023
Q1 | $2.2M | Sell |
54,039
-481
| -0.9% | -$20.8K | 0.69% | 40 |
|
|
2022
Q4 | $2.79M | Buy |
+54,520
| New | +$2.61M | 0.94% | 29 |
|
|
2022
Q2 | $2.78M | Buy |
53,054
+112
| +0.2% | +$5.71K | 1.14% | 24 |
|
|
2022
Q1 | $2.74M | Sell |
52,942
-879
| -2% | -$45.6K | 1.02% | 26 |
|
|
2021
Q4 | $3.18M | Buy |
53,821
+6,732
| +14% | +$334K | 1.18% | 21 |
|
|
2021
Q3 | $2.02M | Sell |
47,089
-4,545
| -9% | -$201K | 0.84% | 33 |
|
|
2021
Q2 | $2.02M | Sell |
51,634
-749
| -1% | -$29.1K | 0.82% | 34 |
|
|
2021
Q1 | $1.9M | Sell |
52,383
-2,299
| -4% | -$81.6K | 0.83% | 31 |
|
|
2020
Q4 | $2.01M | Sell |
54,682
-6,205
| -10% | -$228K | 0.9% | 31 |
|
|
2020
Q3 | $2.12M | Buy |
60,887
+8,226
| +16% | +$288K | 1.07% | 26 |
|
|
2020
Q2 | $1.63M | Buy |
52,661
+13,310
| +34% | +$452K | 0.94% | 26 |
|
|
2020
Q1 | $1.22M | Buy |
39,351
+9,987
| +34% | +$340K | 1.02% | 19 |
|
|
2019
Q4 | $1.09M | Buy |
+29,364
| New | +$1.05M | 0.98% | 25 |
|
|
2019
Q3 | – | Sell |
-29,450
| Closed | -$1.07M | – | 27 |
|
|
2019
Q2 | $1.21M | Buy |
29,450
+107
| +0.4% | +$4.25K | 1.1% | 24 |
|
|
2019
Q1 | $1.18M | Sell |
29,343
-684
| -2% | -$27.4K | 1.09% | 26 |
|
|
2018
Q4 | $1.24M | Buy |
30,027
+150
| +0.5% | +$6.23K | 1.32% | 21 |
|
|
2018
Q3 | $1.25M | Buy |
29,877
+2,526
| +9% | +$97.2K | 1.1% | 24 |
|
|
2018
Q2 | $941K | Buy |
27,351
+1,659
| +6% | +$56.7K | 0.92% | 26 |
|
|
2018
Q1 | $865K | Buy |
25,692
+1,574
| +7% | +$54.1K | 1.13% | 23 |
|
|
2017
Q4 | $829K | Buy |
+24,118
| New | +$822K | 0.86% | 24 |
|
Other funds holding PFE
Quadrant Private Wealth Management's PFE Position: Q2 2026 in Review
Quadrant Private Wealth Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 99,530 shares — an estimated $2.79M sold.
Quadrant Private Wealth Management first reported a position in PFE in Q4 2017 and held it in 32 quarters. The position peaked at $3.91M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Quadrant Private Wealth Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Quadrant Private Wealth Management sold 99,530 Pfizer shares in Q2 2026, an estimated $2.79M.
- Quadrant Private Wealth Management first reported a position in Pfizer in Q4 2017 and held it in 32 quarters.
- Quadrant Private Wealth Management's Pfizer position peaked at $3.91M in Q3 2024.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.